{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:57:30Z","timestamp":1778126250633,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,21]]},"DOI":"10.7759\/cureus.35263","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T16:03:17Z","timestamp":1676995397000},"source":"Crossref","is-referenced-by-count":2,"title":["It Is Not Pneumocystis jiroveci (PCP), It Is Cyclophosphamide-Induced Pneumonitis"],"prefix":"10.7759","author":[{"given":"Mery","family":"Bartl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilen  K","family":"Ng-Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blesset","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose G","family":"Gomez Casanovas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josenny L","family":"Rodriguez- Paez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine E","family":"Loftis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.42.82","article-title":"Cyclophosphamide-induced late-onset lung disease","volume":"42","author":"Hamada K","year":"2003","unstructured":"Hamada K, Nagai S, Kitaichi M, et al.. Cyclophosphamide-induced late-onset lung disease. Intern Med. 2003, 42:82-7. 10.2169\/internalmedicine.42.82","journal-title":"Intern Med"},{"key":"ref2","article-title":"Cyclophosphamide-induced pulmonary toxicity","volume":"7","author":"Siemann DW","year":"1986","unstructured":"Siemann DW, Macler L, Penney DP. Cyclophosphamide-induced pulmonary toxicity. Br J Cancer Suppl. 1986, 7:343-6.","journal-title":"Br J Cancer Suppl"},{"key":"ref3","article-title":"Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience","volume":"35","author":"Mecoli CA","year":"2017","unstructured":"Mecoli CA, Saylor D, Gelber AC, Christopher-Stine L. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience. Clin Exp Rheumatol. 2017, 35:671-3.","journal-title":"Clin Exp Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.15406\/jlprr.2020.07.00232","article-title":"A rare side effect of cyclophosphamide induced acute interstitial pneumonitis: a case report","volume":"7","author":"Thomas SA","year":"2020","unstructured":"Thomas SA, Patel HA. A rare side effect of cyclophosphamide induced acute interstitial pneumonitis: a case report. J Lung Pulm Respir Res. 2020, 7:69-72. 10.15406\/jlprr.2020.07.00232","journal-title":"J Lung Pulm Respir Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2018.11.001","article-title":"Cyclophosphamide-induced lung injury","volume":"4","author":"Pugh D","year":"2019","unstructured":"Pugh D, Farrah TE, Gallacher PJ, Kluth DC, Dhaun N. Cyclophosphamide-induced lung injury. Kidney Int Rep. 2019, 4:484-6. 10.1016\/j.ekir.2018.11.001","journal-title":"Kidney Int Rep"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1164\/ajrccm.154.6.8970380","article-title":"Lung toxicity associated with cyclophosphamide use. Two distinct patterns","volume":"154","author":"Malik SW","year":"1996","unstructured":"Malik SW, Myers JL, DeRemee RA, Specks U. Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med. 1996, 154:1851-6.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref7","article-title":"Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury","volume":"268","author":"Kachel DL","year":"1994","unstructured":"Kachel DL, Martin WJ 2nd. Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury. J Pharmacol Exp Ther. 1994, 268:42-6.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-014-1381-4","article-title":"Acute respiratory failure during first cyclophosphamide infusion in a patient with systemic lupus erythematosus","volume":"73","author":"Schjelderup P","year":"2014","unstructured":"Schjelderup P, El-Galaly TC, Fr\u00f8kj\u00e6r JB, Ring T. Acute respiratory failure during first cyclophosphamide infusion in a patient with systemic lupus erythematosus. Z Rheumatol. 2014, 73:939-41. 10.1007\/s00393-014-1381-4","journal-title":"Z Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000079633","article-title":"Interstitial lung disease induced by drugs and radiation","volume":"71","author":"Camus P","year":"2004","unstructured":"Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration. 2004, 71:301-26. 10.1159\/000079633","journal-title":"Respiration"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-015-0388-3","article-title":"Role of (18)F-FDG PET-CT in monitoring the cyclophosphamide induced pulmonary toxicity in patients with breast cancer - 2 case reports","volume":"50","author":"Taywade SK","year":"2016","unstructured":"Taywade SK, Kumar R, Bhethanabhotla S, Bal C. Role of (18)F-FDG PET-CT in monitoring the cyclophosphamide induced pulmonary toxicity in patients with breast cancer - 2 case reports. Nucl Med Mol Imaging. 2016, 50:261-5. 10.1007\/s13139-015-0388-3","journal-title":"Nucl Med Mol Imaging"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01718-w","article-title":"Prognostic value of radiological findings indeterminate for UIP pattern and anterior upper lobe honeycomb-like lesion in chronic fibrosing interstitial lung disease associated with MPO-ANCA","volume":"21","author":"Yamakawa H","year":"2021","unstructured":"Yamakawa H, Sato S, Nakamura T, et al.. Prognostic value of radiological findings indeterminate for UIP pattern and anterior upper lobe honeycomb-like lesion in chronic fibrosing interstitial lung disease associated with MPO-ANCA. BMC Pulm Med. 2021, 21:346. 10.1186\/s12890-021-01718-w","journal-title":"BMC Pulm Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-022-01078-2","article-title":"Interstitial lung disease in ANCA-associated vasculitis: pathogenic considerations and impact for patients\u2019 outcomes","volume":"24","author":"Sun K","year":"2022","unstructured":"Sun K, Fisher JH, Pagnoux C. Interstitial lung disease in ANCA-associated vasculitis: pathogenic considerations and impact for patients\u2019 outcomes. Curr Rheumatol Rep. 2022, 24:259-67. 10.1007\/s11926-022-01078-2","journal-title":"Curr Rheumatol Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/139223-it-is-not-pneumocystis-jiroveci-pcp-it-is-cyclophosphamide-induced-pneumonitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:54Z","timestamp":1707508374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/139223-it-is-not-pneumocystis-jiroveci-pcp-it-is-cyclophosphamide-induced-pneumonitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.35263","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,21]]}}}